FENT
DEAD

Serial Number

90846994

Owner

INanoBio Inc

Attorney

Jason C. Cameron

First Use Date

Sep 20, 2019

Filing Date

Jul 25, 2021

Add to watchlist:

No watchlists yet
View on USPTO

FENT Trademark

Serial Number: 90846994

FENT is a trademark filed by INanoBio Inc on July 25, 2021. The trademark is classified under Class 9 (Computers & Electronics), Class 10 (Medical Apparatus). The application is currently no longer active.

Owner Contact Info

INanoBio Inc (10 trademarks)

7201 E Henkel Way, Suite 285
Scottsdale, AZ 85255

Entity Type: 03

Trademark Details

Filing Date

July 25, 2021

Registration Date

Not Registered

First Use Anywhere

September 20, 2019

First Use in Commerce

September 20, 2019

Published for Opposition

October 25, 2022

Goods & Services

Semiconductors; Semiconductor apparatus, namely, devices and testing apparatus for molecular analysis and diagnostics and for readout of DNA data storage and DNA memory; Semiconductor devices; Semiconductor chips; Semiconductor devices, namely, semiconductor life science tool power elements; Semiconductor testing apparatus; Transistors; Transistor testers; Medical laboratory research instruments, namely, diagnostic, examination, and monitoring equipment, namely, tools and instruments for molecular analysis and diagnostics and readout of data stored in DNA or other biopolymers; Software as a Medical Device (SaMD), downloadable, for diagnosing prognosis of diseases, namely, cancer, and precision medicine; Medical laboratory research instruments for molecular analysis and diagnostics and precision medicine

Medical diagnostic instruments for molecular analysis, assays, diagnosis of cancer and for precision medicine; Electromedical diagnostic instruments for molecular analysis, diagnosis and prognosis of diseases, namely, cancer, and for precision medicine; Tools for medical diagnostics, namely, diagnostic apparatus for the detection of cancer, namely, life science tools, instruments and systems, namely, medical imaging apparatus with embedded operating system software, for molecular analysis, diagnosis and prognosis of diseases, namely, cancer, and for precision medicine; Diagnostic apparatus for medical purposes, namely, for molecular analysis, diagnosis and prognosis of diseases, namely, cancer, and for precision medicine; Diagnostic instruments for medical use, namely, for molecular analysis, diagnosis and prognosis of diseases, namely, cancer, and for precision medicine; Medical diagnostic, examination, and monitoring equipment, namely, diagnostic apparatus for molecular analysis, diagnosis and prognosis of diseases, namely, cancer, and for precision medicine; Medical diagnostic apparatus for medical purposes, namely, molecular analysis tools for testing DNA and RNA samples, namely, DNA, RNA, and protein sequencing; Apparatus for carrying-out diagnostic tests for medical purposes, namely, tools, systems, namely, medical imaging apparatus with embedded operating system software, and instruments for molecular analysis, diagnosis and prognosis of diseases, namely, cancer, and for precision medicine; Medical apparatus and devices for diagnosis and prognosis of diseases, namely, cancer, and for precision medicine; Medical testing instruments for detecting disease, namely, cancer, early and for precision medicine; Medical analysis instruments for testing DNA, RNA, proteins, metabolites, lipids, multi-omics

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Oct 28, 2024 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Oct 28, 2024 ABN2
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Jul 12, 2024 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Jul 12, 2024 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 15, 2024 GNRN
NON-FINAL ACTION E-MAILED
Apr 15, 2024 GNRT
SU - NON-FINAL ACTION - WRITTEN
Apr 15, 2024 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 6, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 6, 2024 CRFA
ASSIGNED TO LIE
Mar 6, 2024 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 17, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 19, 2023 GNRN
NON-FINAL ACTION E-MAILED
Jul 19, 2023 GNRT
SU - NON-FINAL ACTION - WRITTEN
Jul 19, 2023 CNRT
STATEMENT OF USE PROCESSING COMPLETE
Jul 18, 2023 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jul 17, 2023 AITU
USE AMENDMENT FILED
Jun 20, 2023 IUAF
TEAS STATEMENT OF USE RECEIVED
Jun 20, 2023 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Dec 20, 2022 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 25, 2022 NPUB
PUBLISHED FOR OPPOSITION
Oct 25, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 5, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 20, 2022 CNSA
EXAMINER'S AMENDMENT ENTERED
Sep 19, 2022 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Sep 19, 2022 GNEN
EXAMINERS AMENDMENT E-MAILED
Sep 19, 2022 GNEA
EXAMINERS AMENDMENT -WRITTEN
Sep 19, 2022 CNEA
EXAMINER'S AMENDMENT ENTERED
Aug 30, 2022 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Aug 30, 2022 GNEN
EXAMINERS AMENDMENT E-MAILED
Aug 30, 2022 GNEA
EXAMINERS AMENDMENT -WRITTEN
Aug 30, 2022 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 12, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 11, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 11, 2022 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 15, 2022 GNRN
NON-FINAL ACTION E-MAILED
Feb 15, 2022 GNRT
NON-FINAL ACTION WRITTEN
Feb 15, 2022 CNRT
ASSIGNED TO EXAMINER
Feb 10, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 23, 2021 NWOS
NEW APPLICATION ENTERED
Jul 28, 2021 NWAP